Procter & Gamble Called It “Unscented.” The Ingredients List Told a Different Story.

EvilCorporations.com • Case 1:26-cv-12251 • D. Mass. • Filed May 18, 2026 • Estimated reading time: 6.9 minutes

What This Actually Costs People

Imagine you have sensitive skin. Maybe you’ve spent years figuring out which products set off a rash, which ones leave your neck raw, which ones turn a regular morning into two days of discomfort. You’ve learned to read labels. You’ve paid more for products that promise to be different. You stand in a Walmart aisle, you pick up a stick of deodorant, and the word “UNSCENTED” is right there on the front, not buried in the fine print, not hedged with asterisks, just a clean, clear promise.

You buy it. You trust it. You have no reason not to. After all, P&G is a massive corporation, and one who advertises themselves as being anti-Trump woke too! It’s true, go look up what they’d done in Ohio (Columbus, I think? It’s not relevant to this specific story so I won’t go into more details here).

And then your skin reacts anyway. Or maybe it doesn’t this time, but you find out later what was actually in the product, and you realize that the company that made it knew the whole time. They knew fragrance was in there. They marketed it as unscented anyway, because people who need unscented products will pay more for them, and because most people will never flip the stick over and decode an ingredients list.

The complaint in this case names Lisa Phaneuf, one person, one purchase, Fall 2025, a Walmart in Massachusetts. But the proposed class is every person in the United States who bought this product within the statute of limitations, and the complaint estimates that number in the thousands. Every one of those people made the same reasonable decision: they saw a label that made a specific promise, they believed it, and they paid for it. The promise was false. The company collected the premium anyway.

For people with fragrance allergies or chemical sensitivities, “unscented” is not a preference. It is a medical necessity dressed up as a consumer choice. Fragrance ingredients cause redness, rashes, and itchiness. They are among the most common contact allergens in personal care products. When someone with those sensitivities buys “unscented” and gets fragrance anyway, the cost is not just the $8 or $10 they spent at the register. It is the physical reaction that follows. It is the time spent figuring out what went wrong. It is the realization that the label they trusted was engineered to deceive them.

That is what this case is actually about. Not just a mislabeled stick of deodorant. The systematic extraction of money and trust from people who were trying to protect their own bodies.

Legal Receipts: Straight from the Complaint

These are direct, verbatim quotes from the filed complaint in Phaneuf v. The Procter & Gamble Company, Case 1:26-cv-12251.

“Defendant intentionally misleads consumers into believing that the Products do not contain fragrance ingredients. It does this because consumers desire products without fragrance ingredients can cause skin irritation and allergic reactions. As a result, consumers are seeking out products without fragrance ingredients.”
— Complaint ¶ 5

• The word “intentionally” is load-bearing. This is not an allegation of negligence or a labeling error. The complaint directly alleges that P&G knew the product contained fragrance and labeled it “unscented” anyway, with full knowledge that consumers were buying it specifically to avoid fragrance.
• The complaint connects motive directly to harm: P&G understood that fragrance ingredients cause skin irritation, understood that consumers were seeking products without them, and used that knowledge to market a product that contained the very thing consumers were trying to avoid.

“Plaintiff and Class members would not know the true nature of the Products by looking at the front labels of the Products. There is nothing on the front labels (like an asterisk) disclaiming or modifying the Unscented Representation. The Unscented Representation is not ambiguous or vague to reasonable consumers such that they would reasonably think or be expected to investigate the Unscented Representation further before purchasing the products.”
— Complaint ¶ 24

• This paragraph preemptively destroys the most likely defense P&G will raise: that consumers could have checked the ingredients list on the back. The complaint establishes that the front-of-label “unscented” claim is unqualified, unmodified, and unambiguous. No reasonable shopper is expected to cross-reference the front label against the ingredients panel before trusting a simple, clear factual claim.
• The citation to Cristostomo v. New Balance Athletics, Inc., 647 F. Supp. 3d 1, 8 (D. Mass. 2022) reinforces this in the same district where this case is filed: prominent, unqualified front-label claims cannot be walked back by disclaimers placed elsewhere on the packaging.

“Defendant knew that Plaintiff and Class members would rely on the Unscented Representation and would therefore reasonably believe the Products did not contain fragrance ingredients.”
— Complaint ¶ 29

• This allegation goes directly to the fraud count. Fraud requires knowledge of falsity and intent to induce reliance. The complaint alleges both: P&G knew the claim was false, and knew consumers would rely on it when making their purchase decisions.
• P&G’s own market expertise works against it here. The complaint notes that P&G holds the number two market share position in personal care and generated approximately $910 million in personal care net sales in 2025. A company this sophisticated, this dominant, and this embedded in the personal care market cannot credibly claim ignorance of what “unscented” means to consumers or what its own ingredients lists contain.

“Because this benefit was obtained unlawfully, namely by selling and accepting compensation for the deceptively marketed Products, it would be unjust and inequitable for Defendant to retain it without paying the value thereof.”
— Complaint ¶ 51

• The unjust enrichment count is the financial mechanism behind the lawsuit. P&G collected a price premium from consumers who paid more specifically because the product was marketed as unscented. The complaint argues those consumers are entitled to get that premium back because the promise that justified it was never true.

Public Deception: The Claim vs. The Contents

The entire case rests on a single, documented gap: what P&G told consumers on the front of every package, and what the product actually contained.

• The claim: The front label of Secret Invisible Solid Antiperspirant and Deodorant prominently states the product is “unscented.” The complaint identifies this as the “Unscented Representation” and confirms it appears on every package sold. The reality: The product contains fragrance ingredients, according to the complaint. The word “fragrance” appears in the product’s own ingredients list.
• The claim: No asterisk, no qualifier, no disclaimer modifies the “unscented” statement on the front of the package. A reasonable consumer reading the front label receives a clean, unconditional promise. The reality: The only place fragrance appears is buried in the ingredients panel, which the complaint and supporting case law establish cannot legally undo the misrepresentation made on the front.
• The claim: P&G markets the product to consumers who specifically seek out unscented formulations because they want fewer additives and less potential for skin irritation. The “unscented” label is positioned to capture that demand. The reality: The complaint alleges P&G knowingly sold a product with fragrance to consumers who were paying specifically to avoid fragrance, using their understanding of that consumer need as a marketing tool while providing the opposite of what was promised.

Profit-Maximization at All Costs

The financial context around this alleged deception is not incidental. P&G’s scale makes the “unscented” label a strategic business decision, not a packaging oversight.

• P&G reported $84.3 billion in net sales across all product lines in 2025. Personal care products, which include Secret brand deodorant, represented approximately 6% of that total, or roughly $910 million. The company holds the number two market share position in personal care under its Old Spice, Safeguard, and Secret brands.
• The complaint documents that consumers pay a price premium for unscented personal care products specifically. By labeling a product “unscented” when it contained fragrance, P&G captured that premium from consumers who would not have paid it had they known the truth. The complaint states directly: “Plaintiff and Class members paid a price premium for the Products because of the Unscented Representation.”
• The consumer demand for fragrance-free personal care products is not a niche market. The complaint describes a documented and growing trend: consumers with skin and allergen sensitivities are actively seeking unscented formulations. The complaint notes that “personal care companies — including Defendant — are increasingly introducing unscented product lines to meet consumer demand for minimalist, gentle, non-irritating personal care.” P&G introduced this line to capture that demand while, the lawsuit alleges, not actually delivering on the core promise that defines it.
• The proposed class is nationwide, and the complaint estimates thousands of members. Every one of those transactions involved a price premium collected on the basis of an alleged misrepresentation. Across thousands of purchases, the aggregate extraction of that premium is the financial engine of the unjust enrichment claim.

Societal Impact Mapping

Public Health

The harm here is physical, not abstract. Fragrance ingredients are among the most documented contact allergens in personal care products.

• The complaint establishes that fragrance ingredients in personal care products cause documented physical harms: redness, rashes, and itchiness. Consumers who bought this product specifically to avoid those outcomes were exposed to the very ingredients that produce them.
• People with skin sensitivities and fragrance allergies depend on accurate “unscented” labeling to manage a genuine health need. When that label is false, the product does not just fail to deliver its promise; it actively routes vulnerable consumers toward harm they were trying to avoid.
• The complaint documents that P&G understood this dynamic. The company knew consumers were seeking fragrance-free products specifically because of skin irritation and allergic reaction concerns, and marketed its product directly into that demand without delivering on the promise.

Economic Inequality

People who cannot afford to make repeated experimental purchases, or who lack the time to research every product they buy, carry the largest share of this harm.

• The complaint documents that class members paid a price premium for the “unscented” label. This means the fraud extracted extra money from the people most motivated by price-sensitivity to buy the promise of fewer ingredients and less irritation: people managing skin conditions on a budget, people who shop at Walmart because that is where they can afford to shop.
• The damage per individual class member is relatively small, which the complaint itself acknowledges. This is precisely why individual litigation is described as “virtually impossible” and why the class action mechanism exists. When harms are small per person but massive in aggregate, only collective action forces accountability. Without it, P&G keeps the premium, consumers have no practical recourse, and the incentive to repeat the conduct is undisturbed.
• The class is geographically dispersed across the United States, sold through mass-market retail channels including Walmart. The product was not sold in specialty boutiques to a narrow demographic. The reach of this alleged deception followed the distribution footprint of one of the largest consumer goods companies on earth.

Who Pays? Following the Cost

P&G collected the premium. Consumers absorbed every consequence.

• Consumers paid a price premium for a claim that was false. The complaint is explicit: class members paid more than they would have for a product accurately labeled, and would not have purchased the product at all if they had known the truth. P&G retained that additional money.
• Consumers with genuine fragrance sensitivities absorbed a secondary cost: potential physical harm from exposure to fragrance ingredients they were trying to avoid, plus the time and money required to identify the cause of any resulting skin reaction and find an alternative product.
• The class action mechanism itself represents a cost externalized onto the legal system and onto the plaintiffs and their counsel, who must finance and execute complex litigation to recover losses that, individually, may amount to the price difference between a scented and unscented stick of deodorant.

The Scale of the Machine

This Is the System Working as Intended

The alleged fraud in this case did not happen despite the consumer market’s structure. It happened because of it.

• The class action complaint itself notes that individual damages are “relatively small compared to the burden and expense of individual litigation.” This is the structural mechanism that makes the alleged conduct rational from a corporate perspective: extract a small premium from each of thousands of consumers, and the probability that any single consumer will pursue legal action approaches zero. The expected cost of the fraud is effectively zero until a class action aggregates the harm.
• P&G holds the number two market share position in personal care. That dominance means the company has enormous leverage over retail shelf placement, brand recognition, and consumer trust. A consumer standing in a Walmart aisle does not have the time or the resources to independently verify whether a product labeled “unscented” by one of the world’s largest consumer goods companies actually contains no fragrance. The information asymmetry is built into the transaction.
• The complaint documents that P&G intentionally exploited consumer trust in the “unscented” label specifically because consumer demand for fragrance-free products was growing. The company responded to a genuine, documented consumer health need by introducing a product line that claimed to address it without actually doing so, and collected a premium for the claim.
• The legal precedent cited in the complaint, that a company cannot escape liability by contradicting a front-label claim with fine print on the back, already exists. It was decided before this product was sold. P&G proceeded anyway. The deterrence structure did not stop the conduct; it is now being tested in court, years after the alleged deception began.

What a Legitimate Fix Looks Like

Editorial analysis. The following recommendations are grounded in the documented failure modes of this specific case. They are not findings of the source complaint.

The core structural failure this case exposes: front-label claims in personal care products operate in a low-accountability environment where the cost of a deceptive label is, in practice, only the cost of defending a class action after the fact.

Regulatory Track

• The FDA, which oversees cosmetic and personal care product labeling, should issue binding guidance establishing that an “unscented” or “fragrance-free” front-label claim is a factual representation that cannot be contradicted by the ingredients panel. The current framework relies too heavily on post-market litigation to catch misrepresentation.
• The FTC, which governs deceptive advertising practices, should treat documented front-label claims that contradict ingredient disclosures as per se deceptive under 15 U.S.C. § 45, without requiring plaintiffs to prove harm in each individual case.
• Regulatory agencies should require pre-market label verification for specific factual claims (including “unscented,” “fragrance-free,” “hypoallergenic”) sold to consumers with documented allergy or sensitivity needs. These are not aesthetic claims; they are health-relevant representations.

Legislative Track

• Congress should establish a private right of action with statutory minimum damages for documented front-label misrepresentations in personal care products, removing the burden on consumers to prove exact monetary harm in small-dollar cases where the deception is clear but the individual loss is difficult to quantify.
• State legislatures, particularly in states with active consumer protection frameworks, should pass laws requiring that any “unscented” or “fragrance-free” claim on personal care product packaging be verified against the product formulation on file with a regulatory body before the product is placed on retail shelves.

Corporate Governance Track

• P&G should be required, as part of any resolution of this case, to implement a mandatory internal label-claim verification protocol that cross-references every front-label health-relevant claim against the final product formulation before any product bearing that claim reaches distribution.
• Executive compensation structures at P&G and comparable companies should include a clawback provision tied to class action settlements or regulatory findings of deceptive labeling, removing the incentive to treat consumer deception as an acceptable cost of market positioning.
• The board of directors should be required to receive annual independent audits of all health-relevant label claims across the company’s product portfolio, with audit results disclosed publicly. When a company generates $84.3 billion in annual net sales, “we didn’t know the label was wrong” is not a credible governance defense.

What Now?

The target is The Procter & Gamble Company, an Ohio corporation headquartered in Cincinnati, Ohio. The attorneys bringing this case are Joel D. Smith of Smith Krivoshey, PC (Boston), and Yeremey O. Krivoshey and Brittany S. Scott of Smith Krivoshey, PC (San Francisco).

The case is: Phaneuf v. The Procter & Gamble Company, Case 1:26-cv-12251, United States District Court for the District of Massachusetts, filed May 18, 2026.

Regulatory Watchlist

• FDA (Food and Drug Administration): Oversees cosmetic and personal care product labeling under the Federal Food, Drug, and Cosmetic Act. File a consumer complaint at FDA.gov if you purchased this product and were misled by the “unscented” label.
• FTC (Federal Trade Commission): Enforces against deceptive advertising and marketing practices. Report deceptive product labeling at ReportFraud.ftc.gov.
• State Attorneys General: Consumer protection divisions in Massachusetts and other states have authority to investigate deceptive trade practices. Contact your state AG’s office directly.

On-the-Ground Action

• If you purchased Secret Invisible Solid labeled “unscented”, you may be a class member. Monitor ClassAction.org and SmithKrivoshey.com for updates on how to submit a claim when the case progresses.
• Photograph your product before discarding it. The front label and the ingredients panel together are the core evidence in this case. Document both.
• Share this story with anyone you know who has fragrance sensitivities or buys personal care products specifically for allergy or skin sensitivity reasons. The class requires thousands of members to be effective; awareness of the lawsuit is how they find it.
• Support local mutual aid networks that assist people managing chronic skin conditions, allergies, or chemical sensitivities, particularly those who cannot afford specialist care after a reaction to a mislabeled product.